The human tumor microbiome is composed of tumor type–specific intracellular bacteria D Nejman, I Livyatan, G Fuks, N Gavert, Y Zwang, LT Geller, ... Science 368 (6494), 973-980, 2020 | 1464 | 2020 |
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ... Science 357 (6356), 1156-1160, 2017 | 1389 | 2017 |
KRAS and YAP1 converge to regulate EMT and tumor survival DD Shao, W Xue, EB Krall, A Bhutkar, F Piccioni, X Wang, AC Schinzel, ... Cell 158 (1), 171-184, 2014 | 749 | 2014 |
Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway CA Lovejoy, W Li, S Reisenweber, S Thongthip, J Bruno, T De Lange, ... PLoS genetics 8 (7), e1002772, 2012 | 623 | 2012 |
Endocytosis of receptor tyrosine kinases is driven by monoubiquitylation, not polyubiquitylation Y Mosesson, K Shtiegman, M Katz, Y Zwang, G Vereb, J Szollosi, ... Journal of Biological Chemistry 278 (24), 21323-21326, 2003 | 441 | 2003 |
Tyrosine phosphorylation of Mdm2 by c-Abl: implications for p53 regulation Z Goldberg, RV Sionov, M Berger, Y Zwang, R Perets, RA Van Etten, ... The EMBO journal 21 (14), 3715-3727, 2002 | 255 | 2002 |
p38 MAP kinase mediates stress‐induced internalization of EGFR: implications for cancer chemotherapy Y Zwang, Y Yarden The EMBO journal 25 (18), 4195-4206, 2006 | 216 | 2006 |
Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops C Rubin, V Litvak, H Medvedovsky, Y Zwang, S Lev, Y Yarden Current biology 13 (4), 297-307, 2003 | 216 | 2003 |
An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma MG Baratta, AC Schinzel, Y Zwang, P Bandopadhayay, C Bowman-Colin, ... Proceedings of the National Academy of Sciences 112 (1), 232-237, 2015 | 213 | 2015 |
Conjugation to Nedd8 instigates ubiquitylation and down-regulation of activated receptor tyrosine kinases S Oved, Y Mosesson, Y Zwang, E Santonico, K Shtiegman, MD Marmor, ... Journal of Biological Chemistry 281 (31), 21640-21651, 2006 | 190 | 2006 |
Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding I Amit, L Yakir, M Katz, Y Zwang, MD Marmor, A Citri, K Shtiegman, I Alroy, ... Genes & development 18 (14), 1737-1752, 2004 | 182 | 2004 |
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling K Shtiegman, BS Kochupurakkal, Y Zwang, G Pines, A Starr, A Vexler, ... Oncogene 26 (49), 6968-6978, 2007 | 176 | 2007 |
EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors R Avraham, A Sas-Chen, O Manor, I Steinfeld, R Shalgi, G Tarcic, ... Science signaling 3 (124), ra43-ra43, 2010 | 132 | 2010 |
Systems biology of growth factor‐induced receptor endocytosis Y Zwang, Y Yarden Traffic 10 (4), 349-363, 2009 | 118 | 2009 |
Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals Y Zwang, A Sas-Chen, Y Drier, T Shay, R Avraham, M Lauriola, E Shema, ... Molecular cell 42 (4), 524-535, 2011 | 117 | 2011 |
EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF G Tarcic, R Avraham, G Pines, I Amit, T Shay, Y Lu, Y Zwang, M Katz, ... The FASEB Journal 26 (4), 1582, 2012 | 110 | 2012 |
Polar expression of ErbB-2/HER2 in epithelia: bimodal regulation by Lin-7 M Shelly, Y Mosesson, A Citri, S Lavi, Y Zwang, N Melamed-Book, ... Developmental cell 5 (3), 475-486, 2003 | 84 | 2003 |
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism G Pines, PH Huang, Y Zwang, FM White, Y Yarden Oncogene 29 (43), 5850-5860, 2010 | 81 | 2010 |
Predicting and affecting response to cancer therapy based on pathway-level biomarkers R Ben-Hamo, A Jacob Berger, N Gavert, M Miller, G Pines, R Oren, ... Nature communications 11 (1), 3296, 2020 | 77 | 2020 |
RNF20 and histone H2B ubiquitylation exert opposing effects in Basal-Like versus luminal breast cancer O Tarcic, RZ Granit, IS Pateras, H Masury, B Maly, Y Zwang, Y Yarden, ... Cell Death & Differentiation 24 (4), 694-704, 2017 | 58 | 2017 |